MENU
GH
AS OF
Feb 3, 04:59 PM (EDT)
Price
$113.05
Change
+$47.79 (+73.23%)
Capitalization
14.92B
15 days until earnings call
Intraday BUY SELL Signals
+Compare
GH
Stock ticker: NASDAQ
AS OF
Feb 3, 04:59 PM (EDT)
Price
$113.05
Change
+$47.79 (+73.23%)
Capitalization
14.92B

GH Guardant Health Forecast, Technical & Fundamental Analysis

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use... Show more

GH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for GH with price predictions
Feb 02, 2026

Aroon Indicator for GH shows an upward move is likely

GH's Aroon Indicator triggered a bullish signal on January 28, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 184 similar instances where the Aroon Indicator showed a similar pattern. In of the 184 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 31, 2025. You may want to consider a long position or call options on GH as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GH advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GH moved out of overbought territory on January 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where GH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GH turned negative on January 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GH broke above its upper Bollinger Band on January 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GH's P/B Ratio (60.976) is slightly higher than the industry average of (12.127). P/E Ratio (0.000) is within average values for comparable stocks, (122.497). GH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.899). GH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (15.798) is also within normal values, averaging (12.541).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
GH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

GH is expected to report earnings to rise 97.74% to -77 cents per share on February 19

Guardant Health GH Stock Earnings Reports
Q4'25
Est.
$-0.77
Q3'25
Beat
by $0.40
Q2'25
Beat
by $0.28
Q1'25
Beat
by $0.26
Q4'24
Beat
by $0.16
The last earnings report on October 29 showed earnings per share of -38 cents, beating the estimate of -79 cents. With 666.39K shares outstanding, the current market capitalization sits at 14.92B.
A.I. Advisor
published General Information

General Information

a developer of diagnostic technologies to improve cancer management

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
3100 Hanover Street
Phone
+1 855 698-8887
Employees
1779
Web
https://www.guardanthealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PKW136.951.41
+1.04%
Invesco BuyBack Achievers ETF
PDBA34.15-0.03
-0.09%
Invesco Agriculture Cmdty Str No K-1ETF
MMD15.58-0.02
-0.13%
NYLI MacKay DefinedTerm Muni Opportunities Fund
ALLW28.43-0.38
-1.32%
SPDR Bridgewater ALL Weather ETF
MNRS33.88-0.57
-1.65%
Grayscale Bitcoin Miners ETF

GH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GH has been loosely correlated with NTRA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GH
1D Price
Change %
GH100%
+0.75%
NTRA - GH
52%
Loosely correlated
-0.02%
RGEN - GH
42%
Loosely correlated
+1.17%
GKOS - GH
40%
Loosely correlated
-1.60%
ITGR - GH
40%
Loosely correlated
-1.51%
MASI - GH
40%
Loosely correlated
+0.79%
More